Point72 Asset Management
MRNA icon

Point72 Asset Management’s Moderna MRNA Stock Holding History

Point72 Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.57M Sell
70,300
-52,200
-43% -$2.44M ﹤0.01% 1921
2025
Q4 		$3.61M Sell
122,500
-2,468,200
-95% -$67.1M ﹤0.01% 2071
2025
Q3 		$66.9M Buy
+2,590,700
New +$72.3M 0.11% 204
2021
Q1 		– Sell
-350,000
Closed -$36.6M – 1098
2020
Q4 		$36.6M Buy
350,000
+275,000
+367% +$27.8M 0.18% 147
2020
Q3 		$5.31M Buy
+75,000
New +$5.23M 0.03% 545

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management's MRNA Position: Q1 2026 in Review

Point72 Asset Management opened a new position in Moderna (MRNA) in Q1 2026: 197,844 shares worth $10.1M. The stake represents 0.01% of the portfolio and ranks #1252 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in MRNA as recently as Q4 2018.

Point72 Asset Management first reported a position in MRNA in Q4 2018 and has held it in 2 quarters since. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Point72 Asset Management held 197,844 shares of Moderna worth $10.1M as of Q1 2026.
  • Moderna was a new Point72 Asset Management position in Q1 2026.
  • Moderna made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1252 holding.
  • Point72 Asset Management first reported a position in Moderna in Q4 2018 and has held it in 2 quarters since.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.